Biomimetic nanoparticles: preparation, characterization and biomedical applications

Ana Maria Carmona-RibeiroBiocolloids Lab, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, BrazilAbstract: Mimicking nature is a powerful approach for developing novel lipid-based devices for drug and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ana Maria Carmona-Ribeiro
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/532fda38426f4a16bfb370b95fe264f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:532fda38426f4a16bfb370b95fe264f6
record_format dspace
spelling oai:doaj.org-article:532fda38426f4a16bfb370b95fe264f62021-12-02T01:08:07ZBiomimetic nanoparticles: preparation, characterization and biomedical applications1176-91141178-2013https://doaj.org/article/532fda38426f4a16bfb370b95fe264f62010-04-01T00:00:00Zhttp://www.dovepress.com/biomimetic-nanoparticles-preparation-characterization-and-biomedical-a-a4200https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Ana Maria Carmona-RibeiroBiocolloids Lab, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, BrazilAbstract: Mimicking nature is a powerful approach for developing novel lipid-based devices for drug and vaccine delivery. In this review, biomimetic assemblies based on natural or synthetic lipids by themselves or associated to silica, latex or drug particles will be discussed. In water, self-assembly of lipid molecules into supramolecular structures is fairly well understood. However, their self-assembly on a solid surface or at an interface remains poorly understood. In certain cases, hydrophobic drug granules can be dispersed in aqueous solution via lipid adsorption surrounding the drug particles as nanocapsules. In other instances, hydrophobic drug molecules attach as monomers to borders of lipid bilayer fragments providing drug formulations that are effective in vivo at low drug-to-lipid-molar ratio. Cationic biomimetic particles offer suitable interfacial environment for adsorption, presentation and targeting of biomolecules in vivo. Thereby antigens can effectively be presented by tailored biomimetic particles for development of vaccines over a range of defined and controllable particle sizes. Biomolecular recognition between receptor and ligand can be reconstituted by means of receptor immobilization into supported lipidic bilayers allowing isolation and characterization of signal transduction steps.Keywords: cationic lipid, phospholipids, bilayer fragments, vesicles, silica, polymeric particles, antigens, novel cationic immunoadjuvants, drugs Ana Maria Carmona-RibeiroDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2010, Iss default, Pp 249-259 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Ana Maria Carmona-Ribeiro
Biomimetic nanoparticles: preparation, characterization and biomedical applications
description Ana Maria Carmona-RibeiroBiocolloids Lab, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, BrazilAbstract: Mimicking nature is a powerful approach for developing novel lipid-based devices for drug and vaccine delivery. In this review, biomimetic assemblies based on natural or synthetic lipids by themselves or associated to silica, latex or drug particles will be discussed. In water, self-assembly of lipid molecules into supramolecular structures is fairly well understood. However, their self-assembly on a solid surface or at an interface remains poorly understood. In certain cases, hydrophobic drug granules can be dispersed in aqueous solution via lipid adsorption surrounding the drug particles as nanocapsules. In other instances, hydrophobic drug molecules attach as monomers to borders of lipid bilayer fragments providing drug formulations that are effective in vivo at low drug-to-lipid-molar ratio. Cationic biomimetic particles offer suitable interfacial environment for adsorption, presentation and targeting of biomolecules in vivo. Thereby antigens can effectively be presented by tailored biomimetic particles for development of vaccines over a range of defined and controllable particle sizes. Biomolecular recognition between receptor and ligand can be reconstituted by means of receptor immobilization into supported lipidic bilayers allowing isolation and characterization of signal transduction steps.Keywords: cationic lipid, phospholipids, bilayer fragments, vesicles, silica, polymeric particles, antigens, novel cationic immunoadjuvants, drugs
format article
author Ana Maria Carmona-Ribeiro
author_facet Ana Maria Carmona-Ribeiro
author_sort Ana Maria Carmona-Ribeiro
title Biomimetic nanoparticles: preparation, characterization and biomedical applications
title_short Biomimetic nanoparticles: preparation, characterization and biomedical applications
title_full Biomimetic nanoparticles: preparation, characterization and biomedical applications
title_fullStr Biomimetic nanoparticles: preparation, characterization and biomedical applications
title_full_unstemmed Biomimetic nanoparticles: preparation, characterization and biomedical applications
title_sort biomimetic nanoparticles: preparation, characterization and biomedical applications
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/532fda38426f4a16bfb370b95fe264f6
work_keys_str_mv AT anamariacarmonaribeiro biomimeticnanoparticlespreparationcharacterizationandbiomedicalapplications
_version_ 1718403254682910720